Table 1.
Patients’ baseline characteristics
| Variable | Values |
| Age, yr (± SD) | 63 ± 10 |
| Male gender, n (%) | 265 (81.3) |
| Non-cirrhotic liver, n (%) | 41 (12.5) |
| Child Pugh A/B/C, n (%) | 137 (42)/98 (30)/92 (28) |
| Etiology of liver disease, n (%) | |
| Hepatitis C virus | 99 (30.3) |
| Alcohol | 77 (23.5) |
| NASH | 35 (10.7) |
| Cryptogenic | 37 (11.3) |
| Hepatitis B virus | 22 (6.7) |
| Cholestatic1 | 4 (1.2) |
| Autoimmune | - |
| Hemochromatosis | 6 (1.8) |
| Miscellaneous | 36 (11.0) |
| Comorbidities, n (%) | 141 (43.1) |
| Diabetes mellitus, n (%) | 84 (25.7) |
| Ascites, n (%) | |
| Mild | 76 (23.3) |
| Moderate-severe | 77 (23.5) |
| Encephalopathy, n (%) | |
| Grade I-II | 78 (23.8) |
| Grade III-IV | 6 (1.8) |
| CSPH, n (%) | 212 (64.8) |
| ECOG 0-2, n (%) | 262 (80.1) |
1
Cholestatic: Primary Biliary Cholangitis, Primary and Secondary Sclerosing Cholangitis. NASH: Non-alcoholic steatohepatitis; CSPH: Clinically significant portal hypertension defined as presence of at least one of the following: Ascites, gastroaesophaguel varices or hepatic encephalopathy.